The University of Chicago Header Logo

Connection

John Fung to Age Factors

Back to Details
This is a "connection" page, showing publications John Fung has written about Age Factors.
John Fung
Connection Strength
0.327
Age Factors
  1. Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl. 2008 Oct; 14(10):1406-11.
    View in: PubMed
    Score: 0.059
  2. Is adult-to-adult living donor liver transplantation a viable option for liver replacement? Nat Clin Pract Gastroenterol Hepatol. 2006 Feb; 3(2):70-1.
    View in: PubMed
    Score: 0.049
  3. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg. 2002 Oct; 236(4):429-36; discussion 436-7.
    View in: PubMed
    Score: 0.039
  4. Outcome of kidney transplantation under tacrolimus-based immunosuppression in elderly patients. J Transpl Coord. 1999 Jun; 9(2):101-3.
    View in: PubMed
    Score: 0.031
  5. Liver transplantation under tacrolimus in infants, children, adults, and seniors: long-term results, survival, and adverse events in 1000 consecutive patients. Transplant Proc. 1998 Jun; 30(4):1403-4.
    View in: PubMed
    Score: 0.029
  6. Cadaveric liver donors; what are the limits? Transplant Proc. 1996 Feb; 28(1):21-3.
    View in: PubMed
    Score: 0.025
  7. Impact of donor age in liver transplantation from donation after circulatory death donors: A decade of experience at Cleveland Clinic. Liver Transpl. 2015 Dec; 21(12):1494-503.
    View in: PubMed
    Score: 0.024
  8. Pediatric liver transplantation. A single center experience spanning 20 years. Transplantation. 2002 Mar 27; 73(6):941-7.
    View in: PubMed
    Score: 0.009
  9. Influence of donor condition on postoperative graft survival and function in human liver transplantation. Transplant Proc. 2000 Mar; 32(2):322-6.
    View in: PubMed
    Score: 0.008
  10. A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients. Transplantation. 1999 Feb 15; 67(3):411-5.
    View in: PubMed
    Score: 0.008
  11. Clinical intestinal transplantation: new perspectives and immunologic considerations. J Am Coll Surg. 1998 May; 186(5):512-25; discussion 525-7.
    View in: PubMed
    Score: 0.007
  12. Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. Transplant Proc. 1997 Feb-Mar; 29(1-2):454-5.
    View in: PubMed
    Score: 0.007
  13. "Suboptimal" kidney donors: the experience with tacrolimus-based immunosuppression. Transplantation. 1996 Nov 15; 62(9):1242-6.
    View in: PubMed
    Score: 0.006
  14. Effect of donor age and sex on the outcome of liver transplantation. Hepatology. 1995 Dec; 22(6):1754-62.
    View in: PubMed
    Score: 0.006
  15. One thousand consecutive primary orthotopic liver transplants under FK 506: survival and adverse events. Transplant Proc. 1995 Feb; 27(1):1099-104.
    View in: PubMed
    Score: 0.006
  16. Outcome of liver transplantation using donors 60 to 79 years of age. Transplant Proc. 1995 Feb; 27(1):1184-5.
    View in: PubMed
    Score: 0.006
  17. Liver transplantation under cyclosporine: a decade of experience. Transplant Proc. 1991 Feb; 23(1 Pt 2):1393-6.
    View in: PubMed
    Score: 0.004
  18. Liver transplantation in patients over sixty years of age. Transplantation. 1991 Jan; 51(1):271-3.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.